122 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Kris
    Kris
  4. Miller
    Miller
  5. Norton
    Norton
  6. Dickler
    Dickler
  7. Ginsberg
    Ginsberg
  8. Krug
    Krug
  9. Schwartz
    Schwartz
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (74)
  3. Genitourinary Oncology Service (27)
  4. Survivorship Research (23)
  5. Hematologic Malignancies, Division of (18)
  6. Radiology, Department of (16)
  7. Breast Medicine Service (15)
  8. Center for Hematologic Malignancies (15)
  9. Body Imaging Service (14)
  10. Gastrointestinal Oncology Service (13)
  1. "epistaxis"
Formats
  1. Journal Article (115)
  2. Review (3)
  3. Research Letter (2)
  4. Conference Paper (1)
  5. Correspondence (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (74)
  3. Genitourinary Oncology Service (27)
  4. Survivorship Research (23)
  5. Hematologic Malignancies, Division of (18)
  6. Radiology, Department of (16)

More Groups

People
  1. Robert Motzer (23)
  2. Vincent Miller (9)
  3. Clifford Hudis (8)
  4. Mark Kris (8)
  5. Larry Norton (6)
  6. Lawrence Schwartz (5)

More People

Years
  1. 2025 (5)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Clinical Cancer Research (8)
  3. Cancer (5)
  4. Lancet Oncology (5)
  5. New England Journal of Medicine (5)
  6. Clinical Breast Cancer (4)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. American Society of Clinical Oncology (12)
  3. Wiley Blackwell (10)
  4. American Association for Cancer Research (9)
  5. Elsevier Science, Inc. (8)
  6. Nature Publishing Group (8)

More Publishers

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016
    Research Letter

    Fernandez, J.; Lee, B.; Patel, J. M.; Weiss, E.; Jiang, J.; Dao, H.; Kim, S. J.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Phase I study of trifluridine/tipiracil plus irinotecan and bevacizumab in advanced gastrointestinal tumors
    Journal Article

    Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Makris, L.; Hamada, K.; Berlin, J. D.; Saltz, L. B.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
    Journal Article

    Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
    Cancer Science (2020)

    Fulltext@MSK | Save
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck
    Review

    Hahn, E.; Huang, S. H.; Hosni, A.; Razak, A. A.; Jones, R. L.; Dickson, B. C.; Sturgis, E. M.; Patel, S. G.; O'Sullivan, B.
    Clinical and Translational Radiation Oncology (2019)

    Fulltext@MSK | Save
  • Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
    Journal Article

    Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T. Jr; Trippett, T.; Duell, J.; Bargou, R. C.; Holland, C.; Benjamin, J. E.; more...
    Leukemia (2018)

    Fulltext@MSK | Save
  • A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
    Journal Article

    Stein, E. M.; Walter, R. B.; Erba, H. P.; Fathi, A. T.; Advani, A. S.; Lancet, J. E.; Ravandi, F.; Kovacsovics, T.; DeAngelo, D. J.; Bixby, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer
    Journal Article

    Dunn, L. A.; Fury, M. G.; Sherman, E. J.; Ho, A. A.; Katabi, N.; Haque, S. S.; Pfister, D. G.
    Head & Neck (2018)

    Fulltext@MSK | Save
  • Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma
    Journal Article

    Algazi, A. P.; Esteve-Puig, R.; Nosrati, A.; Hinds, B.; Hobbs-Muthukumar, A.; Nandoskar, P.; Ortiz-Urda, S.; Chapman, P. B.; Daud, A.
    Pigment Cell & Melanoma Research (2018)

    Fulltext@MSK | Save